Sun Pharma Seeks To Acquire German GenericsMaker Stada, Sources Say
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries is eyeing acquisition of Germany’s Stada Arzneimittel, a maker of generics, as part of a plan to invest as much as $1 billion in European companies, according to sources.
Sun Pharmaceutical Industries is eyeing acquisition of Germany’s Stada Arzneimittel, a maker of generics, as part of a plan to invest as much as $1 billion in European companies, according to sources. The Indian drug maker’s plan reportedly was developed in the wake of a European tour of potential targets. Sun said it was not engaged in any negotiations with Stada to buy the company, but would not elaborate on other possible deals. (Click here for more
)
“Sun Pharma Considering Buying German Drug Firm” – Business Standard (India) (8/3/2012)